Latest Ratios: P/E Ratio 6.7x · EV/EBITDA 7.1x · ROE 11.0%. (2020–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $223M | $236M | $126M | $52M | $54M | $12M | — |
| Enterprise Value | $245M | $258M | $102M | $20M | $19M | $-73096520 | — |
| P/E Ratio → | 6.68 | 7.08 | 13.11 | 7.15 | 31.61 | — | — |
| P/S Ratio | 4.10 | 4.34 | 7.02 | 5.23 | 13.44 | 1158.50 | — |
| P/B Ratio | 0.73 | 0.78 | 0.42 | 0.61 | 0.63 | 0.14 | — |
| P/FCF | — | — | — | 9.12 | — | — | — |
| P/OCF | — | — | — | 9.12 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.75 | 5.68 | 1.98 | 4.76 | -7256.68 | — |
| EV / EBITDA | 7.09 | 7.47 | 10.62 | 2.70 | 239.16 | — | — |
| EV / EBIT | 7.09 | 7.47 | 10.62 | 2.70 | 9.72 | — | — |
| EV / FCF | — | — | — | 3.45 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 77.3% | 77.3% | 100.0% | 100.0% | 100.0% | 100.0% | — |
| Operating Margin | 63.6% | 63.6% | 53.5% | 73.2% | 51.0% | -5592.8% | — |
| Net Profit Margin | 61.3% | 61.3% | 53.5% | 73.2% | 42.2% | -5592.8% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | 11.0% | 11.0% | 5.0% | 8.5% | 2.0% | -1.3% | — |
| ROA | 10.2% | 10.2% | 4.8% | 8.4% | 2.0% | -1.3% | -346.9% |
| ROIC | 8.2% | 8.2% | 3.7% | 6.4% | 1.8% | -1.0% | — |
| ROCE | 10.8% | 10.8% | 4.9% | 8.5% | 2.4% | -1.3% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.08 | — | — | — | — | — |
| Debt / EBITDA | 0.72 | 0.72 | — | — | — | — | — |
| Net Debt / Equity | — | 0.07 | -0.08 | -0.38 | -0.41 | -1.00 | — |
| Net Debt / EBITDA | 0.64 | 0.64 | -2.49 | -4.44 | -435.98 | — | — |
| Debt / FCF | — | — | — | -5.67 | — | — | — |
| Interest Coverage | 27.63 | 27.63 | — | — | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | 0.22 | 633.94 | 11.45 | 79.49 | — | — |
| Quick Ratio | 0.22 | 0.22 | 633.94 | 11.45 | 79.49 | — | — |
| Cash Ratio | 0.22 | 0.22 | 633.94 | 10.84 | 76.05 | — | — |
| Asset Turnover | — | 0.16 | 0.06 | 0.11 | 0.05 | 0.00 | — |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | 10.5% | — | — | — | — | — | — |
| Payout Ratio | 69.9% | 69.9% | 129.1% | 112.6% | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 15.0% | 14.1% | 7.6% | 14.0% | 3.2% | — | — |
| FCF Yield | — | — | — | 11.0% | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — | — | — |
| Total Shareholder Yield | 10.5% | — | — | — | — | — | — |
| Shares Outstanding | — | $23M | $10M | $6M | $6M | $877409 | $877409 |
Regulatory dependency on cannabis
As reported in recent financial statements, LIEN trades at a P/B ratio of 0.75, which suggests that the market is pricing the company at a significant discount to its net asset value compared to broader BDC peers.
The current P/E of 6.84 appears to reflect investor caution regarding the sustainability of high-yield cannabis lending rather than a fundamental mispricing of earnings power. This valuation gap warrants further investigation into whether the market is discounting the portfolio for potential credit deterioration or simply applying a blanket risk premium to the entire cannabis-adjacent financial sector.
Based on the provided financial data, LIEN's ROIC has remained relatively modest, fluctuating around 2% in recent quarters, which indicates that the company is still in the early stages of compounding returns on its invested capital.
The current ROIC trend suggests that the firm has yet to achieve the operating leverage necessary to drive significant returns on equity. Investors should monitor whether the transition toward higher debt utilization can improve these returns without compromising the underlying credit quality of the loan portfolio.
According to quarterly filings, LIEN's asset turnover remains low at 0.05, reflecting the capital-intensive nature of a BDC model where revenue is generated primarily through interest income rather than rapid asset rotation.
The lack of a consistent cash conversion cycle suggests that the company's liquidity is highly dependent on the timing of interest payments from borrowers. This reliance on periodic cash inflows may create short-term volatility in the firm's ability to fund its own dividend obligations without external capital raises.
As reported in financial statements, LIEN maintains a very low debt-to-equity ratio of 0.18, which provides a fortress-like balance sheet but simultaneously limits the firm's ability to amplify returns through traditional BDC leverage strategies.
While this conservative stance mitigates interest rate risk, it appears to be a drag on ROE compared to more aggressive peers in the specialty finance space. The company's interest coverage ratio of 9.33 suggests that debt service is currently comfortable, though this may change if the firm decides to increase its leverage to support further portfolio growth.
Based on an analysis of the business model, the P/E ratio is a commonly misapplied metric for LIEN because it fails to account for the non-cash nature of certain income streams and the inherent volatility of Level 3 asset valuations.
Investors should prioritize NAV-based metrics and net investment income (NII) over traditional P/E ratios, as the latter can be distorted by unrealized gains or losses on the loan portfolio. Relying on P/E may obscure the true cash-generating capacity of the underlying credit assets, leading to an inaccurate assessment of the company's dividend-paying ability.
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LIEN stock.
Chicago Atlantic BDC, Inc.'s current P/E ratio is 6.7x. The historical average is 14.7x.
Chicago Atlantic BDC, Inc.'s current EV/EBITDA is 7.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.9x.
Chicago Atlantic BDC, Inc.'s return on equity (ROE) is 11.0%. The historical average is 5.0%.
Based on historical data, Chicago Atlantic BDC, Inc. is trading at a P/E of 6.7x. Compare with industry peers and growth rates for a complete picture.
Chicago Atlantic BDC, Inc.'s current dividend yield is 10.45% with a payout ratio of 69.9%.
Chicago Atlantic BDC, Inc. has 77.3% gross margin and 63.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Chicago Atlantic BDC, Inc.'s Debt/EBITDA ratio is 0.7x, indicating low leverage. A ratio below 2x is generally considered financially healthy.